Palovarotene
ATC M09AX11 · 4 markets · 22 records
AU 11 records · 6 strengths
- 10 mgcapsuleSOHONOSSOHONOS palovarotene 10 mg capsule blister pack
- 5 mgcapsuleSOHONOSSOHONOS palovarotene 10 mg capsule blister pack
- 2.5 mgcapsuleSOHONOSSOHONOS palovarotene 10 mg capsule blister pack
- 1.5 mgcapsuleSOHONOSSOHONOS palovarotene 10 mg capsule blister pack
- 1 mgcapsuleSOHONOSSOHONOS palovarotene 10 mg capsule blister pack
Records without a stated strength · 1 SOHONOS
US 5 records · 5 strengths
CA 5 records · 5 strengths
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 SOHONOS
| Strength / form / release | US | CA | AU | EU |
|---|---|---|---|---|
| 10 mg capsule | SOHONOS | SOHONOS | SOHONOS SOHONOS palovarotene 10 mg capsule blister pack | |
| 5 mg capsule | SOHONOS | SOHONOS | SOHONOS SOHONOS palovarotene 10 mg capsule blister pack | |
| 2.5 mg capsule | SOHONOS | SOHONOS | SOHONOS SOHONOS palovarotene 10 mg capsule blister pack | |
| 1.5 mg capsule | SOHONOS | SOHONOS | SOHONOS SOHONOS palovarotene 10 mg capsule blister pack | |
| 1 mg capsule | SOHONOS | SOHONOS | SOHONOS SOHONOS palovarotene 10 mg capsule blister pack | |
unknown | SOHONOS | SOHONOS |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.